Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Synthesis and characterization of chloroquine-modified albumin-binding siRNA-lipid conjugates for improved intracellular delivery and gene silencing in cancer cellsJustin H Lo, Eva F Gbur, Nora Francini, et al.Molecular Cancer Therapeutics|August 12, 2018
iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic CancerJustin H Lo, Liangliang Hao, Mandar D Muzumdar, et al.Biomaterials|April 9, 2023
Core polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencingShrusti S Patel, Ella N Hoogenboezem, Fang Yu, et al.Cancer Research Communications|February 28, 2025
Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi NanomedicineShrusti S Patel, Rebecca S Cook, Justin H Lo, et al.Biorxiv : the Preprint Server for Biology|June 19, 2023
Albumin-binding RNAi Conjugate for Carrier Free Treatment of ArthritisJuan M Colazo, Ella N Hoogenboezem, Megan C Keech, et al.Nature Biomedical Engineering|May 16, 2025
siRNA conjugate with high albumin affinity and degradation resistance for delivery and treatment of arthritis in mice and guinea pigsJuan M Colazo, Megan C Keech, Veeraj Shah, et al.Biorxiv : the Preprint Server for Biology|February 24, 2023
Structural Optimization of siRNA Conjugates for Albumin Binding Achieves Effective MCL1-Targeted Cancer TherapyElla N Hoogenboezem, Shrusti S Patel, Ashley B Cavnar, et al.Nature Communications|February 21, 2024
Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapyElla N Hoogenboezem, Shrusti S Patel, Justin H Lo, et al.Pageof 2